News & Media
Latest from HealthTech Nexus
Company news, scientific publications, partnerships, and industry insights
HealthTech Nexus Closes Seed Round to Accelerate AI Platform Development
Funding will be deployed to expand Bio R&D and RegIntel platform capabilities, with a focus on expanding into China, Japan, and Southeast Asian markets.
Read more →RegIntel Platform Goes Live with Multi-Country Regulatory Filing Support
The RegIntel platform provides real-time regulatory intelligence for pharma companies navigating NMPA, PMDA, and HSA filings.
HealthTech Nexus Partners with Leading Singapore Biomedical Research Institute
Partnership will pilot the Bio R&D data platform for translational research, covering clinical data management and AI-assisted drug target identification.
Asia-Pacific Pharma Digitalization: 5 Trends Shaping 2026
From AI-accelerated regulatory submissions to GMP digital twins — we break down the key trends transforming life sciences operations across Asia.
AI-Assisted Regulatory Pathway Optimization: A Multi-Country Analysis
Our scientific team publishes findings on applying large language models to accelerate cross-border regulatory submission preparation.
Media Resources
Download brand assets, executive headshots, factsheets, and press materials for media use.